Sichuan Hexie Shuangma (000935.SZ) holding subsidiary Hubei Jianxiang passed the on-site inspection by the US FDA.
Sichuan Shuangma (000935.SZ) announced that the company's holding subsidiary Hubei Jianxiang Biopharmaceutical Co., Ltd. (referred to as"...
Sichuan Hexie Shuangma (000935.SZ) announced that its subsidiary, Hubei Jianxiang Biopharmaceutical Co., Ltd. ("Hubei Jianxiang"), has received an on-site inspection report from the US FDA. According to the inspection report, Hubei Jianxiang's quality and production systems meet the standards of the US FDA and have passed the on-site inspection.
Related Articles
Skyworth Digital (000810.SZ) Several directors and senior executives plan to collectively reduce their holdings by no more than 9.96 million shares.
DTXS SILK ROAD (00620) appoints Cai Hongtu as an independent non-executive director.
US Stock Market Move | After a sharp drop, Tesla, Inc. (TSLA.US) rebounded over 4%. Trump stated "not particularly interested" in talking to Musk.
Skyworth Digital (000810.SZ) Several directors and senior executives plan to collectively reduce their holdings by no more than 9.96 million shares.
DTXS SILK ROAD (00620) appoints Cai Hongtu as an independent non-executive director.
US Stock Market Move | After a sharp drop, Tesla, Inc. (TSLA.US) rebounded over 4%. Trump stated "not particularly interested" in talking to Musk.
